FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tae Won Kim

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Yong Sang Hong; Yoon-Koo Kang; Hyeyoun Kim; Kyu-Pyo Kim; Kyun-Seop Bae; Heung Moon Chang; Jae-Lyun Lee; Hyeong-Seok Lim; Min-Hee Ryu; Tae Won Kim
A phase I study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: Crossover comparisons with intravenous paclitaxel.
Yoon-Koo Kang; Heung Moon Chang; S J Jang; H-Y Jung; G Y Kim; Tae Won Kim; Jae-Lyun Lee; Young Joo Min; S T Oh; B K Park; I Park; Y S Park; Min-Hee Ryu; D H Yang; J H Yook; D Y Zang; B S Kim
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201).
Yong Sang Hong; Hwa Jung Kim; Jin Cheon Kim; Jong Hoon Kim; Kyu-Pyo Kim; Sun Young Kim; Jae-Lyun Lee; Seok-Byung Lim; Jin Hong Park; Seong Joon Park; Chang Sik Yu; Ji Yeon Baek; Tae Won Kim
Second-line cetuximab/irinotecan versus oxaliplatin/fluoropyrimidines for metastatic colorectal cancer with wild-type KRAS.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tae Won Kim (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yong Sang Hong; Yoon-Koo Kang; Hyeyoun Kim; Kyu-Pyo Kim; Kyun-Seop Bae; Heung Moon Chang; Jae-Lyun Lee; Hyeong-Seok Lim; Min-Hee Ryu; Tae Won Kim
A phase I study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: Crossover comparisons with intravenous paclitaxel.
Investigational new drugs 2013;31(3):616-22.
2013: Yoon-Koo Kang; Heung Moon Chang; S J Jang; H-Y Jung; G Y Kim; Tae Won Kim; Jae-Lyun Lee; Young Joo Min; S T Oh; B K Park; I Park; Y S Park; Min-Hee Ryu; D H Yang; J H Yook; D Y Zang; B S Kim
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201).
British journal of cancer 2013;108(6):1245-51.
2013: Yong Sang Hong; Hwa Jung Kim; Jin Cheon Kim; Jong Hoon Kim; Kyu-Pyo Kim; Sun Young Kim; Jae-Lyun Lee; Seok-Byung Lim; Jin Hong Park; Seong Joon Park; Chang Sik Yu; Ji Yeon Baek; Tae Won Kim
Second-line cetuximab/irinotecan versus oxaliplatin/fluoropyrimidines for metastatic colorectal cancer with wild-type KRAS.
Cancer science 2013;104(4):473-80.
2013: Yong Sang Hong; Jee Hyun Kim; Kyu-Pyo Kim; Sun Young Kim; Tae-You Kim; Jeeyun Lee; Jae-Lyun Lee; Keun-Wook Lee; Joon Oh Park; Se Hoon Park; Young Suk Park; Ji Yeon Baek; Tae Won Kim
Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy.
Investigational new drugs 2013;31(1):183-91.
2013: Eun Mi Lee; Ju Hee Lee; Jae-Lyun Lee; Seok-Byung Lim; Young Suk Park; Chang Sik Yu; Doo Ho Choi; Yong Sang Hong; Ah Young Kim; Jin Cheon Kim; Jong Hoon Kim; Kyu-Pyo Kim; Sun Young Kim; Tae Won Kim
Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer.
Cancer science 2013;104(1):111-5.
2013: Yoon-Koo Kang; Tae Won Kim; Jae-Lyun Lee; Do-Youn Oh; Sook Ryun Park; Heung Moon Chang; Seock-Ah Im; Kyung Hae Jung; Byung Woog Kang; Won Ki Kang; Min-Hee Ryu
Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.
Cancer chemotherapy and pharmacology 2013;71(1):43-51.
2012: Seon Ha Kim; Tae Won Kim; Yong Sang Hong; Jung Sung Hwang; Min-Woo Jo
Validity and reliability of the EQ-5D for cancer patients in Korea.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(12):3155-60.
2012: Yong Sang Hong; Sook Jung Jo; Hye Jin Kang; Jee Hyun Kim; Kyu-Pyo Kim; Sun Young Kim; Tae Won Kim; Jeeyun Lee; Kyung Hee Lee; Keun-Wook Lee; Ho Yeong Lim; Young Suk Park; Dong Bok Shin; Sang Joon Shin; Ji Yeon Baek; Sang-Hee Cho; Ik-Joo Chung; Jae Won Lee
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.
The lancet oncology 2012;13(11):1125-32.
2012: Seok-Byung Lim; Jin-Hong Park; Chang Sik Yu; Yong Sang Hong; Jong Hoon Kim; Tae Won Kim; Jin Cheon Kim
Failure patterns correlate with the tumor response after preoperative chemoradiotherapy for locally advanced rectal cancer.
Journal of surgical oncology 2012;106(6):667-73.
2012: Seok-Byung Lim; Chang Sik Yu; Yong Sang Hong; Jong Hoon Kim; Tae Won Kim; Jin Cheon Kim
Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection.
Journal of surgical oncology 2012;106(6):659-66.
2012: Myoung Joo Kang; Shin Ahn; Tae Won Kim; Jae-Lyun Lee; Sung Koo Lee; Sang Soo Lee; Sung Sook Lee; Do Hyun Park; Dong Wan Seo; Myung-Hwan Kim
Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma.
Acta oncologica (Stockholm, Sweden) 2012;51(7):860-6.
2012: Ho Jung An; Heung Moon Chang; Yong Sang Hong; Byung Woog Kang; Yoon-Koo Kang; Jin Cheon Kim; Jong Hoon Kim; Jae-Lyun Lee; Jin Hong Park; Min-Hee Ryu; Chang Sik Yu; Sung-Cheol Yun; Tae Won Kim
Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence.
International journal of radiation oncology, biology, physics 2012;84(1):73-80.
2012: Yong Sik Yoon; Moon Bo Kim; Tae Won Kim; Seon A Roh; Dong Hyung Cho; Yong Sang Hong; Chan Wook Kim; Gyu Pyo Kim; Jin Cheon Kim
Applicability of histoculture drug response assays in colorectal cancer chemotherapy.
Anticancer research 2012;32(8):3581-6.
2012: Myoung Joo Kang; Yoon-Koo Kang; Kyu-Pyo Kim; Mi-Jung Kim; Sun Young Kim; Ji Yeon Baek; Hee Jin Chang; Heung Moon Chang; Yong Sang Hong; Jae-Lyun Lee; Min-Hee Ryu; Tae Won Kim
Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status.
Investigational new drugs 2012;30(4):1607-13.
2012: Changhoon Yoo; Mo Youl Beck; Heung Moon Chang; Tae Won Kim; Jae-Lyun Lee; Baek-Yeol Ryoo; Min-Hee Ryu; Yoon-Koo Kang
Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors: correlation between changes in covariates and imatinib exposure.
Investigational new drugs 2012;30(4):1703-8.
2012: Seung-Woo Hong; Yong Sang Hong; Dong-Hoon Jin; Kyung-Ah Jung; Jin Cheon Kim; Kyu-Pyo Kim; Seung-Mi Kim; Jae-Lyun Lee; Jung-Shin Lee; Jai-Hee Moon; Young-Soon Na; Jae-Sik Shin; Eun Kyung Choi; Tae Won Kim
Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF).
The Journal of biological chemistry 2012;287(28):24017-25.
2012: Seon Ae Roh; Yong Sik Yoon; Dong Hyung Cho; Eun Young Choi; Tae Won Kim; Yong Sung Kim; Jin Cheon Kim
Characterization of biological responses of colorectal cancer cells to anticancer regimens.
Journal of the Korean Surgical Society 2012;83(1):21-9.
2012: Yong Sang Hong; Dong-Hoon Jin; Kyu-Pyo Kim; Seung-Mi Kim; Jae-Lyun Lee; Jung-Shin Lee; Jae-Sik Shin; Dok Hyun Yoon; Dae Seog Heo; Seung-Woo Hong; Tae Won Kim
Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1.
International journal of oncology 2012;41(1):76-82.
2012: Dong Hoe Koo; Jae-Lyun Lee; Sung-Sook Lee; Jung-Hwa Moon; Baek-Yeol Ryoo; Min-Hee Ryu; Heung Moon Chang; Tae Won Kim; Yoon-Koo Kang
Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2012;15(3):305-12.
2012: J-C Jo; Heung Moon Chang; H-S Kim; M Kim; Tae Won Kim; H J Lee; Jae-Lyun Lee; Min-Hee Ryu; J-G Shin; Yoon-Koo Kang
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer.
British journal of cancer 2012;106(10):1591-7.
2012: Jae Berm Park; Heung Moon Chang; Jihun Kim; Pyo Nyun Kim; Song Cheol Kim; Tae Won Kim; Young Hoon Kim; Duck Jong Han
Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
Journal of vascular and interventional radiology : JVIR 2012;23(5):635-41.
2012: Dok Hyun Yoon; Moyeol Beck; Heung Moon Chang; Yoojin Cho; Dae Ro Choi; Tae Won Kim; Jae-Lyun Lee; Baek-Yeol Ryoo; Min-Hee Ryu; Yoon-Koo Kang
Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients.
Investigational new drugs 2012;30(2):819-27.
2012: D H Yoon; Heung Moon Chang; Tae Won Kim; Cheryl T Lee; H J Lee; Jae-Lyun Lee; Y S Park; Baek-Yeol Ryoo; Min-Hee Ryu; Yoon-Koo Kang
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum.
British journal of cancer 2012;106(6):1039-44.
2012: Myoung Joo Kang; Heung Moon Chang; Tae Won Kim; Dong Hoe Koo; Jae-Lyun Lee; Baek-Yeol Ryoo; Min-Hee Ryu; Yoon-Koo Kang
Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience.
European journal of cancer (Oxford, England : 1990) 2012;48(4):492-500.
2012: Young-Soon Na; Min-Hee Ryu; Jae-Sik Shin; Soo-Jin Yang; Dok Hyun Yoon; Yong Sang Hong; Kyung-Ah Jung; Seung-Mi Kim; Jae-Lyun Lee; Jung-Shin Lee; Jai-Hee Moon; Tae Won Kim
YM155 induces EGFR suppression in pancreatic cancer cells.
PloS one 2012;7(6):e38625.
2012: Yoon Hee Choi; Yong Sang Hong; Heung Moon Chang; Ho-Sook Kim; Kyu-Pyo Kim; Tae Won Kim; Jae-Lyun Lee; Sung Sook Lee; Baek-Yeol Ryoo; Min-Hee Ryu; Jae-Gook Shin; Yoon-Koo Kang
A Phase II study of clinical outcomes of 3-week cycles of irinotecan and S-1 in patients with previously untreated metastatic colorectal cancer: influence of the UGT1A1 and CYP2A6 polymorphisms on clinical activity.
Oncology 2012;82(5):290-7.
2012: Seong Joon Park; Min-Hee Ryu; Chang Sik Yu; Jae-Lyun Lee; Young-Soon Na; Yong Chel Ahn; Heung Moon Chang; Yong Sang Hong; Dong-Hoon Jin; Yoon-Koo Kang; Jin Cheon Kim; Kyu-Pyo Kim; Tae Won Kim
Genetic polymorphisms of FcγRIIa and FcγRIIIa are not predictive of clinical outcomes after cetuximab plus irinotecan chemotherapy in patients with metastatic colorectal cancer.
Oncology 2012;82(2):83-9.
2011: Dong Hoe Koo; Jae-Lyun Lee; Sung-Sook Lee; Jung-Hwa Moon; Baek-Yeol Ryoo; Min-Hee Ryu; Heung Moon Chang; Hwa Jung Kim; Tae Won Kim; Yoon-Koo Kang
A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models.
Cancer chemotherapy and pharmacology 2011;68(4):913-21.
2011: Jin-hong Park; Sang Min Yoon; Chang Sik Yu; Jong Hoon Kim; Tae Won Kim; Jin Cheon Kim
Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.
Cancer 2011;117(16):3703-12.
2011: Young-Soon Na; Min-Hee Ryu; Jung-Shin Lee; Dae Hyuk Moon; Dong-Hyung Cho; Yong Sang Hong; Se Jin Jang; Kyung-Ah Jung; Jin Cheon Kim; Seung-Mi Kim; Tae Won Kim
The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
Cancer chemotherapy and pharmacology 2011;68(2):389-98.
2011: Kyu-Pyo Kim; Tae Won Kim; Jae-Lyun Lee; Baek-Yeol Ryoo; Min-Hee Ryu; Changhoon Yoo; Mo Youl Beck; Heung Moon Chang; Dae Ro Choi; Yoon-Koo Kang
Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailability.
Cancer chemotherapy and pharmacology 2011;68(2):285-91.
2011: Kyung Ho Kim; Pyo Nyun Kim; Tae Won Kim; Yong Sik Yoon; Chang Sik Yu; Hyun Kwon Ha; Hye Jin Kim; Jin Cheon Kim
Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases.
Journal of the Korean Surgical Society 2011;81(1):25-34.
2011: Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung Moon Chang; Jeong Hwan Yook; Sung Tae Oh; Byung Sik Kim; Tae Won Kim
Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer.
Cancer chemotherapy and pharmacology 2011;67(6):1435-43.
2011: Jin-hong Park; Eun Kyung Choi; Seung Do Ahn; Sang-Wook Lee; Si Yeol Song; Sang Min Yoon; Young Seok Kim; Yu Sun Lee; Sung-Gyu Lee; Shin Hwang; Young-Joo Lee; Kwang-Min Park; Tae Won Kim; Heung Moon Chang; Jae-Lyun Lee; Jong Hoon Kim
Postoperative chemoradiotherapy for extrahepatic bile duct cancer.
International journal of radiation oncology, biology, physics 2011;79(3):696-704.
2011: Dong Hoe Koo; Jae-Lyun Lee; Young-Joo Lee; Min-Hee Ryu; Sung-Cheol Yun; Heung Moon Chang; Duck Jong Han; Yong Sang Hong; Yoon-Koo Kang; Song Cheol Kim; Tae Won Kim
Adjuvant chemotherapy for small bowel adenocarcinoma after curative surgery.
Oncology 2011;80(3-4):208-13.
2011: Dong Hoe Koo; Jae-Lyun Lee; Baek-Yeol Ryoo; Min-Hee Ryu; Sung-Cheol Yun; Heung Moon Chang; Yong Sang Hong; Yoon-Koo Kang; Tae Won Kim
Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study.
BMC cancer 2011;11():205.
2010: Seung Jin Lee; Seog Young Kim; Jin Hwa Chung; Seung Jun Oh; Jin Sook Ryu; Yong Sang Hong; Tae Won Kim; Dae Hyuk Moon
Induction of thymidine kinase 1 after 5-fluorouracil as a mechanism for 3'-deoxy-3'-[18F]fluorothymidine flare.
Biochemical pharmacology 2010;80(10):1528-36.
2010: Dong-Hyung Cho; Yoon Kyung Jo; Seon Ae Roh; Young-Soon Na; Tae Won Kim; Se Jin Jang; Yong Sung Kim; Jin Cheon Kim
Upregulation of SPRR3 promotes colorectal tumorigenesis.
Molecular medicine (Cambridge, Mass.) 2010;16(7-8):271-7.
2010: Sun Jin Sym; Min-Hee Ryu; Hye Jin Kang; Sung Sook Lee; Heung Moon Chang; Jae-Lyun Lee; Tae Won Kim; Jeong Hwan Yook; Seong Taek Oh; Byung Sik Kim; Yoon-Koo Kang
Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.
Cancer chemotherapy and pharmacology 2010;66(2):373-80.
2010: Sun Jin Sym; Heung Moon Chang; Min-Hee Ryu; Jae-Lyun Lee; Tae Won Kim; Jeong Hwan Yook; Seong Taek Oh; Byung Sik Kim; Yoon-Koo Kang
Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer.
Annals of surgical oncology 2010;17(4):1024-32.
2010: S S Han; M Lee; G H Park; S H Bang; Yoon-Koo Kang; Tae Won Kim; Jae-Lyun Lee; Heung Moon Chang; Min-Hee Ryu
Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokines.
The British journal of dermatology 2010;162(2):371-9.
2009: C Yoo; J Y Hwang; J-E Kim; Tae Won Kim; Jin Seong Lee; Doo Ho Park; Seung-Sook Lee; Dong Wan Seo; Sung Koo Lee; Myung-Hwan Kim; Duck Jong Han; Song Cheol Kim; Jae-Lyun Lee
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer.
British journal of cancer 2009;101(10):1658-63.
2009: Young Seok Kim; Jong Hoon Kim; Sang Min Yoon; Eun Kyung Choi; Seung Do Ahn; Sang-Wook Lee; Jin Cheon Kim; Chang Sik Yu; Hee Chul Kim; Tae Won Kim; Heung Moon Chang
lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
International journal of radiation oncology, biology, physics 2009;74(3):796-802.
2009: Myung-Hwan Kim; Heung Moon Chang; Tae Won Kim; Sung Koo Lee; Jung-Sun Park; Young-Hoon Kim; Tae Yoon Lee; Se Jin Jang; Cheolwon Suh; Tae-Suk Lee; Sang-Hee B Kim; Sung-Gyu Lee
EC-18, a synthetic monoacetyldiacylglyceride, inhibits hematogenous metastasis of KIGB-5 biliary cancer cell in hamster model.
Journal of Korean medical science 2009;24(3):474-80.
2009: Tae Won Kim; Min-Hee Ryu; Heungnam Lee; Sun Jin Sym; Jae-Lyun Lee; Heung Moon Chang; Young Suk Park; Kyung Hee Lee; Won Ki Kang; Dong Bok Shin; Yung-Jue Bang; Jung-Shin Lee; Yoon-Koo Kang
Kinase mutations and efficacy of imatinib in Korean patients with advanced gastrointestinal stromal tumors.
The oncologist 2009;14(5):540-7.
2009: Kyung-Sun Park; Jae-Lyun Lee; Hanjong Ahn; Jung-Min Koh; Inkeun Park; Jun-Seok Choi; Yi Rang Kim; Tai Sun Park; Jin-Hee Ahn; Dae Ho Lee; Tae Won Kim; Jung-Shin Lee
Sunitinib, a novel therapy for anthracycline- and cisplatin-refractory malignant pheochromocytoma.
Japanese journal of clinical oncology 2009;39(5):327-31.
2009: Inkeun Park; Min-Hee Ryu; Sun Jin Sym; Sung Sook Lee; Geundoo Jang; Tae Won Kim; Heung Moon Chang; Jae-Lyun Lee; Hyoungnam Lee; Yoon-Koo Kang
Dose escalation of imatinib after failure of standard dose in Korean patients with metastatic or unresectable gastrointestinal stromal tumor.
Japanese journal of clinical oncology 2009;39(2):105-10.
2009: Byeong Seok Sohn; Tae Won Kim; Jae-Lyun Lee; Min-Hee Ryu; Heung Moon Chang; Yoon-Koo Kang; Hyo Suk Park; Young-Soon Na; Se Jin Jang; Jin Cheon Kim; Jung-Shin Lee
The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients.
Oncology 2009;77(3-4):224-30.
2009: Changhoon Yoo; Jeong-Eun Kim; Shin-Kyo Yoon; Song Cheol Kim; Jin-Hee Ahn; Tae Won Kim; Cheolwon Suh; Jae-Lyun Lee
Angiosarcoma of the retroperitoneum: report on a patient treated with sunitinib.
Sarcoma 2009;2009():360875.
2009: Min-Hee Ryu; Won Ki Kang; Yung-Jue Bang; Kyung Hee Lee; Dong Bok Shin; Baek-Yeol Ryoo; Jae Kyung Roh; Jin-Hyoung Kang; Hyoungnam Lee; Tae Won Kim; Heung Moon Chang; Joon Oh Park; Young Suk Park; Tae-You Kim; Min Kyoung Kim; Woon Kee Lee; Hye Jin Kang; Yoon-Koo Kang
A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor.
Oncology 2009;76(5):326-32.
2009: Byung Woog Kang; Tae Won Kim; Jae-Lyun Lee; Min-Hee Ryu; Heung Moon Chang; Chang Sik Yu; Jin Cheon Kim; Jong Hoon Kim; Yoon-Koo Kang; Jung-Shin Lee
Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis.
Medical oncology (Northwood, London, England) 2009;26(1):32-7.
2008: Jae-Lyun Lee; Yoon-Koo Kang; H J Kang; Kyoo-Hyung Lee; Dae Young Zang; Baek-Yeol Ryoo; Jong Gwang Kim; S R Park; W K Kang; D B Shin; Min-Hee Ryu; Heung Moon Chang; Tae Won Kim; J H Baek; Young Joo Min
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
British journal of cancer 2008;99(4):584-90.
2008: Jin Hyoung Kim; Ho-Young Song; Ji Hoon Shin; Tae Won Kim; Kyung Rae Kim; Sung-Bae Kim; Seung-Il Park; Jong Hoon Kim; Eugene Choi
Palliative treatment of unresectable esophagogastric junction tumors: balloon dilation combined with chemotherapy and/or radiation therapy and metallic stent placement.
Journal of vascular and interventional radiology : JVIR 2008;19(6):912-7.
2008: Sun Jin Sym; Min-Hee Ryu; Jae-Lyun Lee; Heung Moon Chang; Tae Won Kim; Sung Sook Lee; Jung-Shin Lee; Yoon-Koo Kang
Salvage chemotherapy with biweekly irinotecan, plus 5-fluorouracil and leucovorin in patients with advanced gastric cancer previously treated with fluoropyrimidine, platinum, and taxane.
American journal of clinical oncology 2008;31(2):151-6.
2008: In Ja Park; Hee Cheol Kim; Chang Sik Yu; Tae Won Kim; Se Jin Jang; Jin Cheon Kim
Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Annals of surgical oncology 2008;15(2):519-25.
2008: Yoon-Koo Kang; Heung Moon Chang; Tae Won Kim; Min-Hee Ryu; Hyun-Jung Sohn; Jeong Hwan Yook; Seong Taek Oh; Byung Sik Kim; Jin Seong Lee; Yoon-Koo Kang
A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.
British journal of cancer 2008;98(2):316-22.
2008: Heung Moon Chang; Min-Hee Ryu; Hyoungnam Lee; Se Jin Jang; Jae-Lyun Lee; Tae Won Kim; Jeong Hwan Yook; Sung Tae Oh; Byung Sik Kim; Jung-Shin Lee; Yoon-Koo Kang
PDGFRalpha gene mutation and protein expression in gastrointestinal stromal tumors.
Oncology 2008;74(1-2):88-95.
2007: Jae-Cheol Jo; Jae-Lyun Lee; Min-Hee Ryu; Sun Jin Sym; Sung Sook Lee; Heung Moon Chang; Tae Won Kim; Jung-Shin Lee; Yoon-Koo Kang
Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis.
Japanese journal of clinical oncology 2007;37(12):936-41.
2007: Ho-Young Song; Tae-Hyung Kim; Eugene K Choi; Jin Hyoung Kim; Kyung Rae Kim; Ji Hoon Shin; Sung Koo Lee; Tae Won Kim; Jeong Hwan Yook; Byung Sik Kim
Metallic stent placement in patients with recurrent cancer after gastrojejunostomy.
Journal of vascular and interventional radiology : JVIR 2007;18(12):1538-46.
2007: Zheng Qiang Yang; Ho-Young Song; Jin Hyoung Kim; Ji Hoon Shin; Tae Won Kim; Jeong Hwan Yook; Byung Sik Kim
Covered stent placement in patients with recurrent cancer after a Billroth I reconstruction.
Journal of vascular and interventional radiology : JVIR 2007;18(12):1533-7.
2007: Dong Hoe Koo; Jae-Lyun Lee; Tae Won Kim; Heung Moon Chang; Min-Hee Ryu; Sung Sook Lee; Min Kyoung Kim; Sun Jin Sym; Jung-Shin Lee; Yoon-Koo Kang
A Phase II study of cetuximab (Erbitux) plus FOLFIRI for irinotecan and oxaliplatin-refractory metastatic colorectal cancer.
Journal of Korean medical science 2007;22 Suppl():S98-S103.
2007: Min-Hee Ryu; Yoon-Koo Kang; S J Jang; Tae Won Kim; Hyoungnam Lee; Jung Sun Kim; Y H Park; S S Lee; Baek-Yeol Ryoo; Heung Moon Chang; Jae-Lyun Lee; Jeong Hwan Yook; Byung Sik Kim; Jin Seong Lee
Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.
Histopathology 2007;51(3):379-89.
2007: Changhoon Yoo; Min-Hee Ryu; jooryung huh; Ji Hyun Park; Yoon-Koo Kang; Hyo Sook Ahn; Yongjae Lee; Myoung Joon Kim; Hyoungnam Lee; Tae Won Kim; Heung Moon Chang; Jae-Lyun Lee; Yoon-Koo Kang
Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea.
American journal of hematology 2007;82(9):821-3.
2007: Dong Hoe Koo; Jae-Lyun Lee; Tae Won Kim; Heung Moon Chang; Min-Hee Ryu; Jeong Hwan Yook; Seong Taek Oh; Byung Sik Kim; Jin Seong Lee; Yoon-Koo Kang
Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2007;33(7):843-8.
2007: Jin Hyoung Kim; Ho-Young Song; Ji Hoon Shin; Eugene Choi; Tae Won Kim; Hwoon-Yong Jung; Gin Hyug Lee; Sung Koo Lee; Myung-Hwan Kim; Min-Hee Ryu; Yoon-Koo Kang; Byung Sik Kim; Jeong Hwan Yook
Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients.
Gastrointestinal endoscopy 2007;66(2):256-64.
2007: Tae Won Kim; Federico Innocenti
Insights, challenges, and future directions in irinogenetics.
Therapeutic drug monitoring 2007;29(3):265-70.
2007: Jin Hyoung Kim; Ho-Young Song; Ji Hoon Shin; Eugene Choi; Tae Won Kim; Sung Koo Lee; Byung Sik Kim
Stent collapse as a delayed complication of placement of a covered gastroduodenal stent.
AJR. American journal of roentgenology 2007;188(6):1495-9.
2007: Chang Sik Yu; Tae Won Kim; Jong Hoon Kim; Won Sik Choi; Hee Cheol Kim; Heung Moon Chang; Min-Hee Ryu; Se Jin Jang; Seung Do Ahn; Sang-Wook Lee; Seong Soo Shin; Eun Kyung Choi; Jin Cheon Kim
Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer.
International journal of radiation oncology, biology, physics 2007;67(4):1020-6.
2007: Sung Sook Lee; Jae-Lyun Lee; Min-Hee Ryu; Heung Moon Chang; Tae Won Kim; Woo-Kun Kim; Jung-Shin Lee; Se-Jin Jang; Shin Kwang Khang; Yoon-Koo Kang
Extrapulmonary small cell carcinoma: single center experience with 61 patients.
Acta oncologica (Stockholm, Sweden) 2007;46(6):846-51.
2007: Sung Sook Lee; Jae-Lyun Lee; Min-Hee Ryu; Heung Moon Chang; Tae Won Kim; Yoon-Koo Kang; Woo-Kun Kim; Jung-Shin Lee; Yoon-Koo Kang
Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
Japanese journal of clinical oncology 2007;37(1):30-7.
2006: Jae-Lyun Lee; Min-Hee Ryu; Heung Moon Chang; Tae Won Kim; Yoon-Koo Kang; Hyun-Jung Sohn; Jung-Shin Lee; Yoon-Koo Kang
Clinical outcome in gastrointestinal stromal tumor patients who interrupted imatinib after achieving stable disease or better response.
Japanese journal of clinical oncology 2006;36(11):704-11.
2006: Hyun Woo Kim; Sung Sook Lee; Min-Hee Ryu; Jae-Lyun Lee; Heung Moon Chang; Tae Won Kim; Hyun Sook Chi; Woo-Kun Kim; Jung-Shin Lee; Yoon-Koo Kang
A case of leukemic pleural infiltration in atypical chronic myeloid leukemia.
Journal of Korean medical science 2006;21(5):936-9.
2006: Jae-Lyun Lee; Jin Young Kim; Min-Hee Ryu; Yoon-Koo Kang; Heung Moon Chang; Tae Won Kim; Hyoungnam Lee; Ji Hyun Park; Hee Cheol Kim; Jung Sun Kim; Yoon-Koo Kang
Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.
Digestive diseases and sciences 2006;51(6):1043-6.
2006: Ji Seon Oh; Jae-Lyun Lee; Mi-Jung Kim; Min-Hee Ryu; Heung Moon Chang; Tae Won Kim; Se Jin Jang; Jeong Hwan Yook; Sung Tae Oh; Byung Sik Kim; Yoon-Koo Kang
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors of the stomach: report of three cases.
Cancer research and treatment : official journal of Korean Cancer Association 2006;38(3):178-83.
2006: Min-Hee Ryu; Jae-Lyun Lee; Heung Moon Chang; Tae Won Kim; Yoon-Koo Kang; Hyun-Jung Sohn; Jung-Shin Lee; Yoon-Koo Kang
Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate.
Japanese journal of clinical oncology 2006;36(1):17-24.
2005: Jin Cheon Kim; Tae Won Kim; Jong Hoon Kim; Chang Sik Yu; Hee Cheol Kim; Heung Moon Chang; Min-Hee Ryu; Jin Hong Park; Seung Do Ahn; Sang-Wook Lee; Seong Soo Shin; Jung Sun Kim; Eun Kyung Choi
Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer.
International journal of radiation oncology, biology, physics 2005;63(2):346-53.
2005: Hawk Kim; Heung Moon Chang; Min-Hee Ryu; Tae Won Kim; Hyun-Jung Sohn; So-Eun Kim; Yoon-Koo Kang; Sarah Park; Jung-Shin Lee; Yoon-Koo Kang
Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor.
Journal of Korean medical science 2005;20(3):512-5.
2005: Heung Moon Chang; Tae Won Kim; Baek-Yeol Ryu; Seong-Jun Choi; Yeon Hee Park; Jung-Shin Lee; Woo-Kun Kim; Yoon-Koo Kang
Phase II study of paclitaxel and carboplatin in advanced gastric cancer previously treated with 5-fluorouracil and platinum.
Japanese journal of clinical oncology 2005;35(5):251-5.
2005: Yoon-Koo Kang; Heung Moon Chang; Tae Won Kim; Min-Hee Ryu; Hyun-Jung Sohn; Jeong Hwan Yook; Seong Taek Oh; Byung Sik Kim; Jin Seong Lee; Yoon-Koo Kang
Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy.
British journal of cancer 2005;92(2):246-51.
2005: Jeong Hye Kim; Tae Won Kim; Min-Hee Ryu; Heung Moon Chang; Sang Hong Lee; Jung-Shin Lee; Yoon-Koo Kang
A Randomised Crossover Study Comparing Ramosetron plus Dexamethasone with Ramosetron Alone in the Prevention of Cisplatin-Induced Emesis.
Clinical drug investigation 2005;25(3):191-7.
2005: Tae Won Kim; Won Ki Kang; Heung Moon Chang; Joon Oh Park; Baek-Yeol Ryoo; Jin Seok Ahn; Dae Young Zang; Kyung Hee Lee; Yoon-Koo Kang; Sung Rok Kim; Hoon-Kyo Kim
Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial.
Acta oncologica (Stockholm, Sweden) 2005;44(3):230-5.
2004: In Ja Park; Hee Cheol Kim; Chang Sik Yu; Heung Moon Chang; Jea Hwan Lee; Jong Hoon Kim; Tae Won Kim; Jung Sun Kim; Jin Cheon Kim
Responsiveness of CPT-11 in respect to hMLH1 and hMSH2 protein expression in the primary colorectal cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2004;36(6):360-6.
2004: Jin-hong Park; Jong Hoon Kim; Seung Do Ahn; Sang-Wook Lee; Seong Soo Shin; Jin Cheon Kim; Chang Sik Yu; Hee Cheol Kim; Yoon-Koo Kang; Tae Won Kim; Heung Moon Chang; Min Hee Ryu; Eun Kyung Choi
Prospective phase II study of preoperative chemoradiation with capecitabine in locally advanced rectal cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2004;36(6):354-9.
2004: Ho-Young Song; Ji Hoon Shin; Chang Jin Yoon; Gin Hyug Lee; Tae Won Kim; Sung-Koo Lee; Jeong Hwan Yook; Byung-Sik Kim
A dual expandable nitinol stent: experience in 102 patients with malignant gastroduodenal strictures.
Journal of vascular and interventional radiology : JVIR 2004;15(12):1443-9.
2004: Young Seol Heo; Heung Moon Chang; Tae Won Kim; Min-Hee Ryu; Jin-Hee Ahn; Sung Bae Kim; Jung-Shin Lee; Woo-Kun Kim; Hye Kyung Cho; Yoon-Koo Kang
Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy.
Journal of clinical pharmacology 2004;44(10):1166-72.
2004: Jin-Hee Ahn; Sung-Bae Kim; Tae Won Kim; Sei Hyun Ahn; Sun-Mi Kim; Jeong-Mi Park; Jung-Shin Lee; Yoon-Koo Kang; Woo-Kun Kim
Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane.
Journal of Korean medical science 2004;19(4):547-53.
2004: Tae Won Kim; Hyoungnam Lee; Yoon-Koo Kang; Mi Sun Choe; Min-Hee Ryu; Heung Moon Chang; Jung Sun Kim; Jeong Hwan Yook; Byung Sik Kim; Jung-Shin Lee
Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3076-81.
2004: J C Kim; K H Lee; C S Yu; Hyo-Cheol Kim; J R Kim; Heung Moon Chang; Jin Ho Kim; J S Kim; Tae Won Kim
The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2004;30(3):271-9.
2004: Jae-Lyun Lee; Yoon-Koo Kang; Tae Won Kim; Heung Moon Chang; Gyeong-Won Lee; Min-Hee Ryu; Eunkyoung Kim; Seok-Joong Oh; Je-Hwan Lee; Sung-Bae Kim; Sang-We Kim; Cheolwon Suh; Kyoo-Hyung Lee; Jung-Shin Lee; Woo-Kun Kim; Sang-Hee Kim
Leptomeningeal carcinomatosis in gastric cancer.
Journal of neuro-oncology 2004;66(1-2):167-74.
2003: Tae Won Kim; Heung Moon Chang; H J Kang; J R Lee; Min-Hee Ryu; J H Ahn; Jung Hoon Kim; Jin Seong Lee; Yoon-Koo Kang
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1115-20.
2003: Jae-Lyun Lee; Tae Won Kim; Heung Moon Chang; Sung-Koo Lee; Myung-Hwan Kim; Yoon-Koo Kang; Jung Sun Kim; Jong Hoon Kim
Locally advanced acinar cell carcinoma of the pancreas successfully treated by capecitabine and concurrent radiotherapy: report of two cases.
Pancreas 2003;27(1):e18-22.
2003: Jin-Hee Ahn; Tae Won Kim; Je-Hwan Lee; Young Joo Min; Jeong-Gyun Kim; Jin Cheon Kim; Chang Sik Yu; Woo-Kun Kim; Yoon-Koo Kang; Jung-Shin Lee
Oral doxifluridine plus leucovorin in metastatic colorectal cancer: randomized phase II trial with intravenous 5-fluorouracil plus leucovorin.
American journal of clinical oncology 2003;26(1):98-102.
2002: Tae Won Kim; Yoon-Koo Kang; J H Ahn; Heung Moon Chang; Jeong Hwan Yook; Seong Taek Oh; Byung Sik Kim; Jin Seong Lee
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(12):1893-8.
2002: Jin-Hee Ahn; Yoon-Koo Kang; Tae Won Kim; Haeseoung Bahng; Heung Moon Chang; Wee-Chang Kang; Woo-Kun Kim; Jung-Shin Lee; Jung-Sik Park
Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
Cancer chemotherapy and pharmacology 2002;50(2):104-10.
2002: Jung-Hee Lee; Je-Hwan Lee; Jin-Hee Ahn; Hyeseung Bahng; Tae Won Kim; Yoon-Koo Kang; Kyoo-Hyung Lee; Jin Cheon Kim; Chang Sik Yu; Jong-Hoon Kim; Seung Do Ahn; Woo-Kun Kim; Sang-Hee Kim; Jung-Shin Lee
Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1751-8.
2002: Tae Won Kim; Hae Jin Kang; Jin Hee Ahn; Keehyun Lee; Heung Moon Chang; Yoon-Koo Kang; Jung-Shin Lee
Phase II study of gemcitabine, UFT and leucovorin in patients with advanced pancreatic cancer.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):689-94.
2001: Je-Hwan Lee; J H Lee; Tae Won Kim; Kyoo-Hyung Lee; Yoon-Koo Kang; Jin Seong Lee; Sang-Hee Kim; Hee Cheol Kim; Chang Sik Yu; Jin C Kim; Woo-Kun Kim
Combination of oxaliplatin, fluorouracil, and leucovorin in the treatment of fluoropyrimidine-pretreated patients with metastatic colorectal cancer.
Journal of Korean medical science 2001;16(1):69-74.
2000: Young Joo Min; Sang-We Kim; Cheolwon Suh; J Park; Ho Jeong Kim; Jong Gwang Kim; Tae Won Kim; Je-Hwan Lee; Soon Bae Kim; Kyoo-Hyung Lee; Jin Seong Lee; Woo-Kun Kim; Sang-Hee Kim
The possible cost effectiveness of peripheral blood stem cell mobilization with cyclophosphamide and the late addition of G-CSF.
Journal of Korean medical science 2000;15(1):49-52.
1998: Tae Won Kim; Woo-Kun Kim; Je-Hwan Lee; Soon Bae Kim; Sang-We Kim; Cheolwon Suh; Kyoo-Hyung Lee; Jin Seong Lee; Eul-Ju Seo; Hyun Sook Chi; Sang-Hee Kim
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
Journal of Korean medical science 1998;13(6):587-90.